| NDC Code | 55910-851-20 |
|---|
| Package Description | 1 BOTTLE, PLASTIC in 1 BOX (55910-851-20) / 20 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC |
|---|
| Product NDC | 55910-851 |
|---|
| Product Type Name | HUMAN OTC DRUG |
|---|
| Proprietary Name | Naproxen Sodium |
|---|
| Non-Proprietary Name | Naproxen Sodium |
|---|
| Dosage Form | CAPSULE, LIQUID FILLED |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20220103 |
|---|
| End Marketing Date | 20250331 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA202807 |
|---|
| Manufacturer | Dolgencorp, Inc. (DOLLAR GENERAL & REXALL) |
|---|
| Substance Name | NAPROXEN SODIUM |
|---|
| Strength | 220 |
|---|
| Strength Unit | mg/1 |
|---|
| Pharmacy Classes | Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC] |
|---|